Discover how accruals affect company finances, with insights into the accrual accounting method, its applications, and ...
Ginkgo Bioworks faces ongoing revenue declines and high cash burn, despite cost-cutting efforts and partnerships with major firms like Pfizer and Merck. The company's Q3 2024 revenue was inflated by ...
Rigel Pharmaceuticals (NASDAQ:RIGL) delivered much higher GAAP revenue and profits than analysts expected for Q2 2025, boosted by both strong product sales and non-cash collaboration revenue. Net ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results